Skip to main content
Erschienen in: Current Hypertension Reports 4/2017

01.04.2017 | Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Microbial Short-Chain Fatty Acids and Blood Pressure Regulation

verfasst von: Jennifer L. Pluznick

Erschienen in: Current Hypertension Reports | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Microbial short-chain fatty acids (SCFAs) are byproducts of microbial metabolism which can be absorbed into the bloodstream of the host, where they exert effects on host physiology. SCFAs have been known to influence several aspects of host physiology, including the regulation of blood pressure. In this review, we will consider recent studies linking SCFAs to blood pressure regulation.

Recent Findings

Several recent studies have found that changes in blood pressure often coordinate with expected changes in SCFAS. Efforts are now well underway to dissect and better understand this potential connection. One way that SCFAs can influence host cells is by interacting with host GPCRs, including Gpr41 and Olfr78, among others. Intriguingly, mice null for Olfr78 are hypotensive, whereas mice null for Gpr41 are hypertensive, implying that these pathways may be physiologically important links between SCFAs and host blood pressure control.

Summary

In sum, these studies demonstrate that there does indeed appear to be a link between SCFAs and blood pressure, which likely involves host GPCRs, at least in part; however, the details and intricacies of these interactions are not yet fully understood and will greatly benefit from further studies.
Literatur
1.
Zurück zum Zitat •• Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331–40. This paper showed that changes in the gut microbiota, including changes in SCFA-producing bacteria, are associated with hypertension in the SHR model; in addition, this study provides evidence that gut dysbiosis occurs in human hypertension CrossRefPubMedPubMedCentral •• Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331–40. This paper showed that changes in the gut microbiota, including changes in SCFA-producing bacteria, are associated with hypertension in the SHR model; in addition, this study provides evidence that gut dysbiosis occurs in human hypertension CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat • Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G-protein coupled receptor 41. Physiol Genomics. 2016;physiolgenomics 00089 2016. This paper demonstrated that Gpr41 null animals have a phenotype including isolated systolic hypertension, further indicating a role for SCFAs and SCFA receptors in blood pressure regulation. • Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G-protein coupled receptor 41. Physiol Genomics. 2016;physiolgenomics 00089 2016. This paper demonstrated that Gpr41 null animals have a phenotype including isolated systolic hypertension, further indicating a role for SCFAs and SCFA receptors in blood pressure regulation.
3.
Zurück zum Zitat • Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013;110(11):4410–5. This paper demonstrated that Olfr78 null animals have a phenotype including lowered plasma renin, indicating a role for SCFAs and SCFA receptors in blood pressure regulation CrossRefPubMedPubMedCentral • Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013;110(11):4410–5. This paper demonstrated that Olfr78 null animals have a phenotype including lowered plasma renin, indicating a role for SCFAs and SCFA receptors in blood pressure regulation CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat •• Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat model. Physiol Genomics. 2015;47(6):187–97. This paper provided evidence for a link between gut microbiota and blood pressure in the Dahl salt-sensitive rat model of hypertension, including measurement of plasma SCFA levels CrossRefPubMedPubMedCentral •• Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat model. Physiol Genomics. 2015;47(6):187–97. This paper provided evidence for a link between gut microbiota and blood pressure in the Dahl salt-sensitive rat model of hypertension, including measurement of plasma SCFA levels CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat • Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, et al. Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension. 2016;67(2):469–74. This paper demonstrated changes in the gut microbiota in the rat obstructive sleep apnea/high fat diet model of hypertension, including changes in SCFA-producing microbiota PubMed • Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, et al. Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension. 2016;67(2):469–74. This paper demonstrated changes in the gut microbiota in the rat obstructive sleep apnea/high fat diet model of hypertension, including changes in SCFA-producing microbiota PubMed
6.
Zurück zum Zitat Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159–66.CrossRefPubMed Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159–66.CrossRefPubMed
7.
Zurück zum Zitat Hoverstad T, Midtvedt T. Short-chain fatty acids in germfree mice and rats. J Nutr. 1986;116(9):1772–6.PubMed Hoverstad T, Midtvedt T. Short-chain fatty acids in germfree mice and rats. J Nutr. 1986;116(9):1772–6.PubMed
8.
Zurück zum Zitat Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, et al. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature. 2016;534(7606):213–7.CrossRefPubMedPubMedCentral Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, et al. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature. 2016;534(7606):213–7.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Cummings JH, Hill MJ, Bone ES, Branch WJ, Jenkins DJ. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr. 1979;32(10):2094–101.PubMed Cummings JH, Hill MJ, Bone ES, Branch WJ, Jenkins DJ. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr. 1979;32(10):2094–101.PubMed
10.
Zurück zum Zitat den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325–40.CrossRef den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325–40.CrossRef
11.
Zurück zum Zitat Levrat MA, Remesy C, Demigne C. High propionic acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulin. J Nutr. 1991;121(11):1730–7.PubMed Levrat MA, Remesy C, Demigne C. High propionic acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulin. J Nutr. 1991;121(11):1730–7.PubMed
12.
Zurück zum Zitat Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64(4):897–903.CrossRefPubMed Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension. 2014;64(4):897–903.CrossRefPubMed
13.
Zurück zum Zitat Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23(3):475–81.CrossRefPubMed Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23(3):475–81.CrossRefPubMed
14.
Zurück zum Zitat Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008;453(7193):396–400.CrossRefPubMed Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008;453(7193):396–400.CrossRefPubMed
15.
Zurück zum Zitat Keshaviah PR. The role of acetate in the etiology of symptomatic hypotension. Artif Organs. 1982;6(4):378–87.CrossRefPubMed Keshaviah PR. The role of acetate in the etiology of symptomatic hypotension. Artif Organs. 1982;6(4):378–87.CrossRefPubMed
16.
Zurück zum Zitat Pagel MD, Ahmad S, Vizzo JE, Scribner BH. Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Kidney Int. 1982;21(3):513–8.CrossRefPubMed Pagel MD, Ahmad S, Vizzo JE, Scribner BH. Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Kidney Int. 1982;21(3):513–8.CrossRefPubMed
17.
Zurück zum Zitat Marques FZ, Nelson EM, Chu PY, Horlock D, Fiedler A, Ziemann M, et al. High fibre diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in DOCA-salt hypertensive mice. Circulation. 2016. Marques FZ, Nelson EM, Chu PY, Horlock D, Fiedler A, Ziemann M, et al. High fibre diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in DOCA-salt hypertensive mice. Circulation. 2016.
18.
Zurück zum Zitat Adnan S, Nelson JW, Ajami NJ, Venna VR, Petrosino JF, Bryan RM, Jr., et al. Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genomics. 2016;physiolgenomics 00081 2016. Adnan S, Nelson JW, Ajami NJ, Venna VR, Petrosino JF, Bryan RM, Jr., et al. Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genomics. 2016;physiolgenomics 00081 2016.
19.
Zurück zum Zitat Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312–9.CrossRefPubMed Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312–9.CrossRefPubMed
20.
Zurück zum Zitat Le PE, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278(28):25481–9.CrossRef Le PE, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278(28):25481–9.CrossRef
21.
Zurück zum Zitat Liaw CW, Connolly DT. Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42. DNA Cell Biol. 2009;28(11):555–60.CrossRefPubMed Liaw CW, Connolly DT. Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42. DNA Cell Biol. 2009;28(11):555–60.CrossRefPubMed
22.
Zurück zum Zitat Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009;69(7):2826–32.CrossRefPubMedPubMedCentral Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009;69(7):2826–32.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40(1):128–39.CrossRefPubMedPubMedCentral Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40(1):128–39.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, et al. (D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem. 2005;280(29):26649–52.CrossRefPubMed Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, et al. (D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem. 2005;280(29):26649–52.CrossRefPubMed
25.
Zurück zum Zitat Neuhaus EM, Zhang W, Gelis L, Deng Y, Noldus J, Hatt H. Activation of an olfactory receptor inhibits proliferation of prostate cancer cells. J Biol Chem. 2009;284(24):16218–25.CrossRefPubMedPubMedCentral Neuhaus EM, Zhang W, Gelis L, Deng Y, Noldus J, Hatt H. Activation of an olfactory receptor inhibits proliferation of prostate cancer cells. J Biol Chem. 2009;284(24):16218–25.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Gelis L, Jovancevic N, Veitinger S, Mandal B, Arndt HD, Neuhaus EM, et al. Functional characterization of the odorant receptor 51E2 in human melanocytes. J Biol Chem. 2016;291(34):17772–86.CrossRefPubMed Gelis L, Jovancevic N, Veitinger S, Mandal B, Arndt HD, Neuhaus EM, et al. Functional characterization of the odorant receptor 51E2 in human melanocytes. J Biol Chem. 2016;291(34):17772–86.CrossRefPubMed
28.
Zurück zum Zitat Chang AJ, Ortega FE, Riegler J, Adison DVM, Krasnow MA. Oxygen regulation of breathing through an olfactory receptor activated by lactate. Nature. 2015;527(7577):240–4.CrossRefPubMedPubMedCentral Chang AJ, Ortega FE, Riegler J, Adison DVM, Krasnow MA. Oxygen regulation of breathing through an olfactory receptor activated by lactate. Nature. 2015;527(7577):240–4.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Aisenberg WH, Huang J, Zhu W, Rajkumar P, Cruz R, Santhanam L, et al. Defining an olfactory receptor function in airway smooth muscle cells. Sci Rep. 2016;6:38231.CrossRefPubMedPubMedCentral Aisenberg WH, Huang J, Zhu W, Rajkumar P, Cruz R, Santhanam L, et al. Defining an olfactory receptor function in airway smooth muscle cells. Sci Rep. 2016;6:38231.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Zhou T, Chien MS, Kaleem S, Matsunami H. Single cell transcriptome analysis of mouse carotid body glomus cells. J Physiol. 2016;594(15):4225–51.CrossRefPubMed Zhou T, Chien MS, Kaleem S, Matsunami H. Single cell transcriptome analysis of mouse carotid body glomus cells. J Physiol. 2016;594(15):4225–51.CrossRefPubMed
31.
Zurück zum Zitat Nutting CW, Islam S, Daugirdas JT. Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. Am J Phys. 1991;261(2 Pt 2):H561–H7. Nutting CW, Islam S, Daugirdas JT. Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. Am J Phys. 1991;261(2 Pt 2):H561–H7.
32.
Zurück zum Zitat Mortensen FV, Nielsen H, Mulvany MJ, Hessov I. Short chain fatty acids dilate isolated human colonic resistance arteries. Gut. 1990;31(12):1391–4.CrossRefPubMedPubMedCentral Mortensen FV, Nielsen H, Mulvany MJ, Hessov I. Short chain fatty acids dilate isolated human colonic resistance arteries. Gut. 1990;31(12):1391–4.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Nutting CW, Islam S, Ye MH, Batlle DC, Daugirdas JT. The vasorelaxant effects of acetate: role of adenosine, glycolysis, lyotropism, and pHi and Cai2+. Kidney Int. 1992;41(1):166–74.CrossRefPubMed Nutting CW, Islam S, Ye MH, Batlle DC, Daugirdas JT. The vasorelaxant effects of acetate: role of adenosine, glycolysis, lyotropism, and pHi and Cai2+. Kidney Int. 1992;41(1):166–74.CrossRefPubMed
34.
Zurück zum Zitat Knock G, Psaroudakis D, Abbot S, Aaronson PI. Propionate-induced relaxation in rat mesenteric arteries: a role for endothelium-derived hyperpolarising factor. J Physiol. 2002;538(Pt 3):879–90.CrossRefPubMedPubMedCentral Knock G, Psaroudakis D, Abbot S, Aaronson PI. Propionate-induced relaxation in rat mesenteric arteries: a role for endothelium-derived hyperpolarising factor. J Physiol. 2002;538(Pt 3):879–90.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes. 2014;5(2):202–7.CrossRefPubMed Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes. 2014;5(2):202–7.CrossRefPubMed
Metadaten
Titel
Microbial Short-Chain Fatty Acids and Blood Pressure Regulation
verfasst von
Jennifer L. Pluznick
Publikationsdatum
01.04.2017
Verlag
Springer US
Erschienen in
Current Hypertension Reports / Ausgabe 4/2017
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-017-0722-5

Weitere Artikel der Ausgabe 4/2017

Current Hypertension Reports 4/2017 Zur Ausgabe

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

The Gut, Its Microbiome, and Hypertension

Hypertension and Metabolic Syndrome (J Sperati, Section Editor)

Role of Orexin-A in Hypertension and Obesity

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Oral Microbiome and Nitric Oxide: the Missing Link in the Management of Blood Pressure

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Gastrointestinal Tract: a Promising Target for the Management of Hypertension

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Gut Microbiome in Chronic Kidney Disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.